A placebo-controlled trial of antibiotics for smaller skin abscesses

New England Journal of Medicine

Volumn 376, Issue 26, 2017, Pages 2545-2555

  Daum, Robert S ^a   Miller, Loren G ^b   Immergluck, Lilly ^d   Fritz, Stephanie ^e   Creech, C Buddy ^f   Young, David ^c   Kumar, Neha ^a   Downing, Michele ^c   Pettibone, Stephanie ^g   Hoagland, Rebecca ^h   Eells, Samantha J ^b   Boyle, Mary G ^e   Parker, Trisha Chan ^d   Chambers, Henry F ^c  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d EMORY UNIVERSITY   (United States)

^e BARNES JEWISH HOSPITAL   (United States)

^f VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g EMMES CORPORATION   (United States)

^h Cota Enterprises ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; PLACEBO; ANTIINFECTIVE AGENT;

ABSCESS DRAINAGE; ADOLESCENT; ADULT; ALLERGIC REACTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATION; CELLULITIS; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FEMALE; FEVER; FOLLOW UP; HEPATITIS; HUMAN; INFANT; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MULTICENTER STUDY; NAUSEA; NONHUMAN; OUTPATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RASH; RISK BENEFIT ANALYSIS; SKIN ABSCESS; SKIN INCISION; STAPHYLOCOCCUS INFECTION; TABLET; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT OUTCOME; ABSCESS; CLINICAL TRIAL; DRAINAGE; ISOLATION AND PURIFICATION; MULTIMODALITY CANCER THERAPY; PRESCHOOL CHILD; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

ABSCESS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLINDAMYCIN; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; DRAINAGE; FEMALE; HUMANS; INFANT; INTENTION TO TREAT ANALYSIS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PROSPECTIVE STUDIES; SKIN DISEASES, BACTERIAL; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION;

EID: 85021693678     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1607033     Document Type: Article

References (17)

1. Miller LG, Eisenberg DF, Liu H, et al. Incidence of skin and soft tissue infections in ambulatory and inpatient settings, 2005-2010. BMC Infect Dis 2015; 15: 362.
2. Lipsky BA, Kollef MH, Miller LG, Sun X, Johannes RS, Tabak YP. Predicting bacteremia among patients hospitalized for skin and skin-structure infections: derivation and validation of a risk score. Infect Control Hosp Epidemiol 2010; 31: 828-37.
3. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355: 666-74.
4. David MZ, Daum RS. Communityassociated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev 2010; 23: 616-87.
5. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011; 52: 285-92.
6. Talan DA, Mower WR, Krishnadasan A, et al. Trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med 2016; 374: 823-32.
7. Miller LG, Daum RS, Creech CB, et al. Clindamycin versus trimethoprim-sulfamethoxazole for uncomplicated skin infections. N Engl J Med 2015; 372: 1093-103.
8. Fitch MT, Manthey DE, McGinnis HD, Nicks BA, Pariyadath M. Abscess incision and drainage. N Engl J Med 2007; 357(19): e20.
9. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria which grow aerobically: approved standard. 10th ed. CLSI document M07-A10. Wayne, PA: CLSI, January 2015.
10. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010; 152: 726-32.
11. Lee MC, Rios AM, Aten MF, et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J 2004; 23: 123-7.
12. Schmitz GR, Bruner D, Pitotti R, et al. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med 2010; 56: 283-7.
13. Rajendran PM, Young D, Maurer T, et al. Randomized, double-blind, placebocontrolled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection. Antimicrob Agents Chemother 2007; 51: 4044-8.
14. Duong M, Markwell S, Peter J, Barenkamp S. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med 2010; 55: 401-7.
15. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis 2014; 59(2): e10-e52.
16. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52(3): e18-e55.
17. Holmes L, Ma C, Qiao H, et al. Trimethoprim-sulfamethoxazole therapy reduces failure and recurrence in methicillinresistant Staphylococcus aureus skin abscesses after surgical drainage. J Pediatr 2016; 169: 128-34.e1.